EUVIMEDEUVIMED entdecken
Crossref

Retrospective analysis of cytology and high‐risk HPV testing in 1067 endocervical adenocarcinomas and precursor lesions

Lei Ye, Meifu Gan, Yeli Yao, Bingjian Lu iD

Cancer Cytopathology · 2024

DOI: 10.1002/cncy.22802 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cytopathology, 2024. Verfasst von Lei Ye und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Pathology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections, Adenocarcinoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cytology and high‐risk human papilloma virus (hrHPV) cotesting is the mainstay in the detection of cervical carcinoma.

Methods

Endocervical adenocarcinoma (EAC) is divided into HPV‐associated adenocarcinoma (HPVA) and HPV‐independent adenocarcinoma (HPVI) by the World Health Organization classification (2020). The detection effect of cotesting is suggested to be different among EAC subtypes and precursors, but has not well‐documented yet. In this study, the authors retrospectively analyzed cotesting among adenocarcinoma in situ (AIS), HPVA, and HPVI. The cohort included 569 AIS and 498 EAC consisting of 371 (74.5%) HPVA, 111 (22.3%) HPVI, and 16 (3.2%) adenocarcinoma, not otherwise specified.

Results

The authors found that AIS patients were significantly younger than HPVA and HPVI (mean ± SD, years: 40.7 ± 8.6; HPVA, 44.8 ± 9.3; HPVI, 50.0 ± 11.3; p < .001) and had a higher prevalence of concurrent squamous intraepithelial lesions (75.5%, HPVA, 37.2%; HPVI, 12.6%; p < .001). The detection rate of hrHPV test or cytology was substantially higher in AIS and HPVA than in HPVI (97.7% and 90.2% vs. 16.5%, p < .001, or 71.1% and 71.9% vs. 60.7%, p = .042, respectively). Cytology and hrHPV cotesting was superior to a single test in the detection of EAC and AIS. The detection rate of cotesting amounted to 100% in AIS and 94.3% in HPVA but was substantially lower in HPVI (72.2%) ( p < .001).

Conclusions

The authors conclude that cytology and hrHPV cotesting can maximize the detection effect for HPVA and AIS but is not optimal for HPVI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsPapillomavirus InfectionsAdenocarcinomaHumansFemaleRetrospective StudiesAdultMiddle AgedPapillomaviridaeVaginal SmearsUterine Cervical DysplasiaCytodiagnosisPrecancerous ConditionsAdenocarcinoma in Situ

Stichwörter der Autor:innen

adenocarcinoma in situcotestingcytologyendocervical adenocarcinomahigh‐risk human papilloma virus

Autor:innen und Institutionen

  • Department of Surgical Pathology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China.
  • Department of Surgical Pathology, Taizhou Hospital, Wenzhou Medical University, Taizhou, Zhejiang Province, China.
  • Department of Gynecologic Oncology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China.
  • Department of Surgical Pathology and Zhejiang Provincial Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Zhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Wo…

ORCID-Profile: Bingjian Lu

Zitieren

APA

Ye, L., Gan, M., Yao, Y., & Lu, B. (2024). Retrospective analysis of cytology and high‐risk HPV testing in 1067 endocervical adenocarcinomas and precursor lesions. Cancer Cytopathology. https://doi.org/10.1002/cncy.22802

Vancouver

Ye L, Gan M, Yao Y, Lu B. Retrospective analysis of cytology and high‐risk HPV testing in 1067 endocervical adenocarcinomas and precursor lesions. Cancer Cytopathology. 2024. doi:10.1002/cncy.22802

BibTeX
@article{Ye2024,
  author = {Ye, Lei and Gan, Meifu and Yao, Yeli and Lu, Bingjian},
  title = {Retrospective analysis of cytology and high‐risk HPV testing in 1067 endocervical adenocarcinomas and precursor lesions},
  journal = {Cancer Cytopathology},
  year = {2024},
  doi = {10.1002/cncy.22802}
}
Kostenlos starten →